Clinical Updates
OTC Flonase Expected to Be Available in Early 2015
The FDA has recently approved Flonase Allergy Relief to be an OTC treatment for temporary…
Louisiana: Carisoprodol (Soma) Placed in Schedule II Classification
Act 397 (SB 618) of 2014 Legislature – effective August 1. 2014. This law places…
FDA Approves New Extended-Release Oxycodone with Abuse-Deterrent Properties
“Today, the U.S. Food and Drug Administration approved Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride…
Launch of Generic Diovan
The generic equivalent of Diovan (valsartan) has just been released, following FDA approval. Diovan is…
Re-Launch of Generic Astepro
The generic equivalent of Astepro (azelastine) has just been re-launched, following FDA approval. Astepro is…
DEA Finalizes Rule to Schedule Tramadol
On July 2, 2014, the Drug Enforcement Administration (DEA) published in the Federal Register the…
Launch of Generic Testim® 1% gel
The generic equivalent of Testim® 1% gel (testosterone gel) has just been released, following FDA…
Launch of Generic Actonel 150mg
The generic equivalent of Actonel 150mg (risendronate sodium tablets) has just been released, following FDA…
Launch of Generic Pennsaid 1.5%
The generic equivalent of Pennsaid 1.5% (diclofenac sodium topical solution) has just been released, following…
New Medication Update: Nexium® 24HR
Pfizer, Inc. has announced the introduction in the U.S. of over-the-counter (OTC) Nexium® 24HR. The…
